Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.

Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):83-92.

Více informací ZDE 

Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):536-545.

Více informací ZDE 

Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.

Radiother Oncol. 2022 Jan;166:26-32.

Více informací ZDE 

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.

Lancet Oncol. 2022 Jan;23(1):104-114.

Více informací ZDE 

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.

Lancet. 2022 Jan 29;399(10323):447-460.

Více informací ZDE 

Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.

Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):390-399.

Více informací ZDE 

Parotid Gland Stem Cell Sparing Radiation Therapy for Patients With Head and Neck Cancer: A Double-Blind Randomized Controlled Trial.

Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):306-316.

Více informací ZDE 

Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial.

Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):294-303.

Více informací ZDE 

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.

Lancet Oncol. 2022 Feb;23(2):259-269.

Více informací ZDE 

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial.

Lancet Oncol. 2022 Feb;23(2):220-233.

Více informací ZDE 

Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma.

Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):926-937.

Více informací ZDE 

Patient-Reported Outcomes in the Acute Phase of the Randomized Hypofractionated Irradiation for Prostate Cancer (HYPRO) Trial.

Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):870-879.

Více informací ZDE 

Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled Trial.

Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):880-889.

Více informací ZDE 

Impact of Dose-Escalated Chemoradiation on Quality of Life in Patients With Locally Advanced Rectal Cancer: 2-Year Follow-Up of the Randomized RECTAL-BOOST Trial.

Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):694-703.

Více informací ZDE 

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.

N Engl J Med. 2022 Mar 10;386(10):923-932.

Více informací ZDE 

Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.

J Clin Oncol. 2022 Mar 10;40(8):866-875.

Více informací ZDE 

1